Morgan Stanley’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,031
| Closed | -$608 | – | 8270 |
|
|
2024
Q4 | $608 | Hold |
1,031
| – | – | ﹤0.01% | 7326 |
|
|
2024
Q3 | $813 | Hold |
1,031
| – | – | ﹤0.01% | 7254 |
|
|
2024
Q2 | $1.31K | Sell |
1,031
-6
| -0.6% | -$8 | ﹤0.01% | 7125 |
|
|
2024
Q1 | $1.44K | Buy |
1,037
+211
| +26% | +$293 | ﹤0.01% | 7125 |
|
|
2023
Q4 | $1.31K | Buy |
826
+413
| +100% | +$657 | ﹤0.01% | 7177 |
|
|
2023
Q3 | $586 | Hold |
413
| – | – | ﹤0.01% | 7292 |
|
|
2023
Q2 | $657 | Sell |
413
-30
| -7% | -$48 | ﹤0.01% | 7350 |
|
|
2023
Q1 | $372 | Hold |
443
| – | – | ﹤0.01% | 7462 |
|
|
2022
Q4 | $629 | Hold |
443
| – | – | ﹤0.01% | 7533 |
|
|
2022
Q3 | $1K | Hold |
443
| – | – | ﹤0.01% | 7621 |
|
|
2022
Q2 | $1K | Sell |
443
-60
| -12% | -$135 | ﹤0.01% | 7717 |
|
|
2022
Q1 | $2K | Sell |
503
-300
| -37% | -$1.19K | ﹤0.01% | 7769 |
|
|
2021
Q4 | $3K | Buy |
803
+300
| +60% | +$1.12K | ﹤0.01% | 7754 |
|
|
2021
Q3 | $3K | Sell |
503
-900
| -64% | -$5.37K | ﹤0.01% | 7615 |
|
|
2021
Q2 | $14K | Buy |
1,403
+900
| +179% | +$8.98K | ﹤0.01% | 7139 |
|
|
2021
Q1 | $4K | Buy |
503
+413
| +459% | +$3.28K | ﹤0.01% | 7170 |
|
|
2020
Q4 | $0 | Buy |
+90
| New | – | ﹤0.01% | 7136 |
|